HDDO-1756 Bio Equivalence Study

Clinical trial NCT04755894 · COMPLETED

Trial details

NCT number: NCT04755894
Sponsor: Hyundai Pharmaceutical Co., LTD.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hyperlipidemias

Start date: 2020-06-12
Primary completion: 2020-06-19
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.